FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40169111000001105: Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2070681000001112 Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2070691000001114 Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Is a Azacitidine 100mg powder for suspension for injection vials 1 vial true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has AMP Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has dispensed dose form Powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has specific active ingredient Azacitidine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start